Professor Andrew Hopkins D.Phil. FRCS has agreed to join the Scientific Advisory Board of the Myrovlytis Trust. Andrew is Professor of Medicinal Informatics, Biological Chemistry and Drug Discovery Division, at the University of Dundee, and also holds the Scottish Universities Life Science Alliance Chair for Translational Biology. His expertise is in drug discovery having spent several years at Pfizer, most recently as Head of Chemical Genomics, Associate Research Fellow. Professor Hopkins currently consults or advises for several organisations, including the World Health Organisation, OECD, and St Jude Children’s Research Hospital, Memphis, Tennessee. The Trust is delighted that Professor Hopkins has joined the Board.